Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P21
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-82.63%
Q3 2025-43.66%
Q2 2025-16.58%
Q1 202539.91%
Q4 2024-45.90%
Q3 2024-15.58%
Q2 202441.04%
Q1 202429.99%
Q4 2023-42.18%
Q3 2023539.95%
Q2 2023-76.23%
Q1 2023-78.61%
Q4 2022648.18%
Q3 2022-119.17%
Q2 202272.01%
Q1 2022-58.98%
Q4 202141.95%
Q3 20211.64%
Q2 20218.86%
Q1 2021-137.85%
Q4 2020-963.61%
Q3 20200.47%
Q2 2020-12.24%
Q1 2020129.32%
Q4 2019-141.66%
Q3 2019-229.51%
Q2 2019196.97%
Q1 2019-208.94%
Q4 2018600.00%
Q3 201870.31%
Q2 2018-16.84%
Q1 2018-118.21%
Q4 20173337.83%
Q3 2017-3237.50%
Q2 201795.00%
Q1 20170.00%
Q4 20160.00%
Q3 20160.00%
Q2 20160.00%
Q1 20160.00%